Inhalt drucken


Webinar: Financing in times of COVID19 for Basel-based Life Science and Hightech start-ups, Standortförderung Basel-Stadt, Standortförderung Baselland

Dear Ladies and Gentlemen,

The corona crisis is keeping the global economy on edge. For start-ups the situation is particularly precarious as their funding runway and milestones are tightly calculated and a global pandemic is usually not part of a risk analysis. On top of that, initial public support is oriented at wages and annual revenue, both criteria that largely exclude start-ups from these measures.

Together with Alexander Mayweg from Versant Ventures/Ridgeline Therapeutics, Pascal Winnen from Hemex and life sciences serial entrepreneur Roger Meier, the Basel-Stadt Economic Development Unit AWA, the Basel-Landschaft Economic Development and aim to address this challenge.

In this webinar we will discuss:

- how COVID-19 may be affecting early stage investors (seed/SerA) & company builder investors
- how COVID-19 may be affecting Series B and X-over investors for follow-on rounds
- impact on valuations and deal pace
- major operational issues and mitigations for biotech during COVID lockdowns
- how different types of investors are affected by COVID-19
- how start-ups in different maturity stages deal with the situation
- the special importance of investor relations during the crisis
- how private investors currently think and operate
- impact on valuations and deal pace as well as mitigation strategies


The webinar will include a Q&A part with the opportunity to discuss individual situations and questions.
Please submit your questions beforehand here to allow the speakers to prepare.

When: Wednesday, 22.04.2020, 13:00-14:30
Platform: Zoom (link after registration)


13:00   How COVID19 affects start-ups

Participants report their experiences

13:10   Welcome & introduction

Karin Sartorius, Life Sciences Manager Economic Development AWA Basel-Stadt
Dr. Robert Sum, Corporate Support Life Sciences & Innovation Economic Development Basel-Land
Dr. Adrian Sprenger, Manager Entrepreneurship

13:15   Speakers

Dr. Alexander Mayweg, Managing Director & Dr. Fang Ni Principle, both at Versant Ventures
Pascal Winnen, CEO of HEMEX AG
Roger Meier, Entrepreneur in life sciences

13:45   Q&A

14:30   End

Participation to the event is free of charge; however your registration by 21.04.2020 is kindly required.


For further information and to confirm your participation or to register additional participants, please visit the website.


Kind regards

Karin Sartorius-Brüschweiler
Life Sciences Manager, Canton of Basel-Stadt

Robert Sum
Corporate Support Life Sciences & Innovation Economic Development, Canton of Basel-Land

Dr. Adrian Sprenger
Manager Entrepreneurship,

Datum & Zeit

Mi. 22. April 2020

13:00 - 14:30 Uhr


Platform: Zoom (link after registration)